ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Opioid Peptides: Potential for Drug Development
| dc.contributor.author | Aldrich, Jane V. | |
| dc.contributor.author | McLaughlin, Jay P. | |
| dc.date.accessioned | 2017-03-08T20:11:36Z | |
| dc.date.available | 2017-03-08T20:11:36Z | |
| dc.date.issued | 2013-04-01 | |
| dc.identifier.citation | Aldrich, Jane V., and Jay P. Mclaughlin. "Opioid Peptides: Potential for Drug Development." Drug Discovery Today: Technologies 9.1 (2012): n. pag. | en_US |
| dc.identifier.uri | http://hdl.handle.net/1808/23368 | |
| dc.description.abstract | Opioid receptors are important targets for the treatment of pain and potentially for other disease states (e.g. mood disorders and drug abuse) as well. Significant recent advances have been made in identifying opioid peptide analogs that exhibit promising in vivo activity for treatment of these maladies. This review focuses on the development and evaluation of opioid peptide analogs demonstrating activity after systemic administration, and recent clinical evaluations of opioid peptides for possible therapeutic use. | en_US |
| dc.publisher | Elsevier | en_US |
| dc.rights | This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | en_US |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ | |
| dc.title | Opioid Peptides: Potential for Drug Development | en_US |
| dc.type | Article | en_US |
| kusw.kuauthor | Aldrich, Jane V. | |
| kusw.kudepartment | Pharmaceutical Chemistry | en_US |
| dc.identifier.doi | 10.1016/j.ddtec.2011.07.007 | en_US |
| kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
| kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
| dc.rights.accessrights | openAccess |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
